arrow
P

Paul E. Ronksley

University of Calgary
H指数:54
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A systematic review and meta-analysis of the relationship between midlife physical activity and later-life cognition: Is sex as an overlooked factor?

一项关于中年期身体活动与晚年认知关系的中系统评价和荟萃分析:性别是否为一个被忽视的因素?

2026-04-080
OAAI
Impact of risk mitigation measures on oral fluoroquinolone prescribing: a multi-site population-based Canadian cohort study

风险缓解措施对口服氟喹诺酮类药物处方的影响:一项多中心基于人群的加拿大队列研究

2026-03-250
OAAI
Practice Variation in Prescribing SGLT2-Inhibitors: A Population-Based Analysis from Alberta, Canada

Kanji, R.; Chew, D.S.; Au, F.; Campbell, D.J.T.; Lau, D.; Beall, R.F.; Ronksley, P.E.; Manns, B.; Quinn, A.E. 药物处方中SGLT2抑制剂的应用差异:来自加拿大阿尔伯塔省的基于人群的分析。CJC Open 2025, 8, 283–291. [Google Scholar] [CrossRef]

2026-03-011
PRE
Variability in eGFR and the Risk of Adverse Kidney Outcomes and All-Cause Mortality A Retrospective Observational Study Based on National General Practice Dataset

eGFR的变异性与不良肾脏结局和全因死亡风险:一项基于全国基层医疗数据库的回顾性观察研究

2026-02-010
PRE
Frequency of follow-up testing for tissue transglutaminase antibodies after initial positivity among children: An analysis of real-world data from a population-based cohort in Canada

儿童初次检测组织转谷氨酰胺酶抗体阳性后随访检测频率:一项基于加拿大基于人群队列的真实世界数据分析

2026-02-010
PRE
Sex Differences in Associations Between Measures of Hemodialysis Adequacy and Quality, Cardiovascular Outcomes, and Mortality: A Systematic Review

性别差异在评估指标(如血液透析充分性和质量)、心血管结局及死亡率之间的关联性:一项系统评价

2026-01-050
OAAI
Patterns of follow-up testing of abnormal eGFR and UACR for the detection of chronic kidney disease in Australian primary care: analysis of a national general practice dataset

澳大利亚初级保健中异常eGFR和UACR随访检测模式的慢性肾病筛查:一项全国综合诊所数据集分析

2025-10-010
OAAI
Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

2型糖尿病伴与不伴慢性肾脏病患者SGLT2抑制剂和GLP1受体激动剂处方的应用现状:一项基于澳大利亚初级保健数据集的分析

2025-07-160
OAAI